Redox signaling of NF-κB by membrane NAD(P)H oxidases in normal and malignant cells

Protoplasma

Volumn 221, Issue 1-2, 2003, Pages 117-127

  Brar, S S ^a   Kennedy, T P ^a   Quinn, M ^b   Hoidal, J R ^c  

^a CAROLINAS MEDICAL CENTER   (United States)

^b MONTANA STATE UNIVERSITY   (United States)

^c UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

Author keywords

Melanoma; NAD(P)H oxidase subunit gp91phox; NAD(P)H oxidase subunit p22phox; NADPH oxidase; Nuclear factor B; Superoxide anion

Indexed keywords

ANIMALS; HUMANS; MELANOMA; MUSCLE, SMOOTH; NADPH OXIDASE; NF-KAPPA B; OXIDATION-REDUCTION; SKIN NEOPLASMS;

EID: 0038687134     PISSN: 0033183X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00709-002-0059-y     Document Type: Conference Paper

References (43)

1. 2 production requires the activation of phosphatidylinositol 3-kinase. J Biol Chem 275: 10527-10531
2. Baldwin AS (2001) Control of oncogenesis and cancer therapy resistance by the transcription factor NF-κB. J Clin Invest 107: 241-246
3. Bargou RC, Emmerich F, Drappmann D, Bommert K, Mapara MY, Arnold W, Royer HD, Grinstein E, Greiner A, Scheidereit C, Dorken B (1997) Constitutive nuclear factor-κB-Rel A activation is required for proliferation and survival of Hodgkin's disease tumor cells. J Clin Invest 100: 2961-2969
4. Batra RK, Gutteridge DC, Brenner DA, Dubinett SM, Baldwin AS, Boucher RC (1999) IκBα gene transfer is cytotoxic to squamous-cell lung cancer cells and sensitizes them to tumor necrosis factor-α-mediated cell death. Am J Respir Cell Mol Biol 21: 238-245
5. Beg AA, Ruben SM, Scheinman RI, Haskill S, Rosen CA, Baldwin AS Jr (1992) IκB interacts with the nuclear localization sequences of the subunits of NF-κB: a mechanism for cytoplasmic retention. Genes Dev 6: 1899-1913
6. Bellas RE, Lee JS, Sonenshein GE (1995) Expression of a constitutive NF-κB-like activity is essential for proliferation of cultured bovine vascular smooth muscle cells. J Clin Invest 96: 2521-2527
7. Bours V, Dejardin E, Goujon-Letaawe F, Merville MP, Castronovo B (1994) The NF-κB transcription factor and cancer: high expression of NF-κB- and IκB-related protein in tumor cell lines. Biochem Pharmacol 47: 145-149
8. Brar SS, Kennedy TP, Whorton AR, Murphy TM, Chitano P, Hoidal JR (1999) Requirement for reactive oxygen species in serum-induced and platelet-derived growth factor-induced growth of airway smooth muscle. J Biol Chem 274: 20017-20026
9. _ Sturrock AB, Huecksteadt TP, Ghio AJ, Hoidal JR (2001) Reactive oxygen species from NAD(P)H:quinone oxidoreductase constitutively activate NF-κB in malignant melanoma cells. Am J Physiol Cell Physiol 280: C659-C676
10. _ Sturrock AB, Huecksteadt TP, Quinn MR, Murphy TM, Chitano P, Hoidal JR (2002a) An NAD(P)H oxidase promotes NF-κB activation and proliferation in human airway smooth muscle. Am J Physiol Lung Cell Mol Physiol 282: L782-L795
11. _ Quinn MT, Whorton AR, Hoidal JR (2002b) An NAD(P)H oxidase regulates growth and transcription in melanoma cells. Am J Physiol Cell Physiol 282: C1212-C1224
12. phox: cloning and tissue expression of Nox3, Nox4, and Nox5. Gene 269: 131-140
13. Duffey DC, Chen Z, Dong G, Ondrey FG, Wolf JS, Brown K, Siebenlist U, Van Waes C (1999) Expression of a dominant-negative mutant inhibitor-κBα of nuclear factor-κB in human head and neck squamous cell carcinoma inhibits survival, proinflammatory cytokine expression, and tumor growth in vivo. Cancer Res 59: 3468-3474
14. Gopalkrishna R, Jaken S (2000) Protein kinase C signaling and oxidative stress. Free Radic Biol Med 28: 1349-1361
15. phox containing NADPH oxidase selectively expressed in endothelial cells is a major source of oxygen radical generation in the arterial wall. Circ Res 87: 26-32
16. Griendling KK, Sorescu D, Ushio-Fukai M (2000) NAD(P)H oxidase: role in cardiovascular biology and disease. Circ Res 86: 494-501
17. Gustin JA, Maehama T, Dixon JE, Donner DB (2001) The PTEN tumor suppressor protein inhibits tumor necrosis factor-induced nuclear factor-κB activity. J Biol Chem 276: 27740-27744
18. Gutteridge DC, Albanese C, Reuther JY, Pestell RG, Baldwin AS Jr (1999) NF-kappa B controls cell growth and differentiation through transcriptional regulation of cyclin D1. Mol Cell Biol 19: 5785-5799
19. Han Y, Runge MS, Brasier AR (1999) Angiotensin II induces interleukin-6 transcription in vascular smooth muscle cells through pleiotropic activation of nuclear factor-kappa B transcription factors. Circ Res 84: 695-703
20. Higgins KA, Perez JR, Coleman TA, Dorshkind K, McComas WA, Sarmiento UM, Rosen CA, Narayanan R (1993) Antisense inhibition of the p65 subunit of NF-κB blocks tumorigenicity and causes tumor regression. Proc Natl Acad Sci USA 90: 9901-9905
21. Hinz M, Krappmann D, Eichten A, Heder A, Scheidereit C, Strauss M (1999) NF-κB function in growth control: regulation of cyclin D1 expression and G0/G1-to-S phase transition. Mol Cell Biol 19: 2690-2698
22. Irani K (2001) Angiotensin II-stimulated vascular remodeling: the search for the culprit oxidase. Circ Res 88: 858-860
23. Kaltschmidt B, Kaltschmidt C, Hehner SP, Droge W, Schmitz ML (1999) Repression of NF-κB impairs HeLA cell proliferation by functional interference with cell cycle checkpoint regulators. Oncogene 18: 3213-3225
24. phox homologs in vascular smooth muscle cells: Nox1 mediates angiotensin II-induced superoxide formation and redox-sensitive signaling pathways. Circ Res 88: 888-894
25. Li N, Karin M (1999) Is NF-kappaB the sensor of oxidative stress? FASEB J 13: 1137-1142
26. Lin X, O'Mahony A, Mu Y, Geleziunas R, Greene WC (2000) Protein kinase C-θ participates in NF-κB activation induced by CD3-CD28 costimulation through selective activation of IκB kinase β. Mol Cell Biol 20: 2933-2940
27. Lin Y-Z, Yao SY, Veach RA, Torgerson TR, Hawiger J (1995) Inhibition of nuclear translocation of transcription factor NF-κB by a synthetic peptide containing a cell membrane-permeable motif and nuclear localization sequence. J Biol Chem 270: 14255-14258
28. Marumo T, Schini-Kerth VB, Fisslthaler B, Busse R (1997) Platelet-derived growth factor-stimulated superoxide anion production modulates activation of transcription factor NF-κB and expression of monocyte chemoattractant protein 1 in human aortic smooth muscle cells. Circulation 96: 2361-2367
29. Ogata N, Yamamoto H, Kugiyama K, Yasue H, Miyamoto E (2000) Involvement of protein kinase C in superoxide anion-induced activation of nuclear factor-κB in human endothelial cells. Cardiovasc Res 45: 513-521
30. O'Mahony A, Lin X, Geleziunas R, Greene WC (2000) Activation of the heterodimeric IκB kinase α (IκKα)-IκKβ complex is directional: IκKα regulates IκKβ under both basal and stimulated conditions. Mol Cell Biol 20: 1170-1178
31. Palombella VJ, Rando OJ, Goldberg AL, Maniatis T (1994) The ubiquintin-proteasome pathway is required for processing the NF-κB precursor protein and the activation of NF-κB. Cell 78: 773-785
32. Pueyo ME, Gonzalez W, Nicolletti A, Savoie F, Arnal JF, Michel JB (1999) Angiotensin II stimulates endothelial vascular cell adhesion molecule-1 via nuclear factor-kappaB activation induced by intracellular oxidative stress. Arterioscler Thromb Vasc Biol 20: 645-651
33. Sambo P, Baroni SS, Luchetti M, Paroncini P, Duse S, Orlandini G, Gabrielli A (2001) Oxidative stress in scleroderma: maintenance of scleroderma fibroblast phenotype by the constitutive up-regulation of reactive oxygen species generation through the NADPH oxidase complex pathway. Arthritis Rheum 44: 2653-2664
34. Schieffer B, Luchtefeld M, Braun S, Hilfiker A, Hilfiker-Kleiner D, Drexler H (2000) Role of NAD(P)H oxidase in angiotensin II-induced JAK/STAT signaling and cytokine induction. Circ Res 87: 1192-1201
35. Schreck R, Rieber P, Baeuerle PA (1991) Reactive oxygen intermediates as apparently widely used messengers in the activation of the NF-κB transcription factor and HIV-1. EMBO J 10: 2247-2258
36. Shattuck-Brandt RL, Richmond AL (1997) Enhanced degradation of I-κBα contributes to endogenous activation of NF-κB in Hs294 melanoma cells. Cancer Res 57: 3032-3039
37. Sovak MA, Bellas RE, Kim DW, Zanieski GJ, Rogers AE, Traish TM, Sonenshein GE (1997) Aberrant nuclear factor-κB/Rel expression and the pathogenesis of breast cancer. J Clin Invest 100: 2952-2960
38. Tak PP, Firestein GS (2001) NF-κB: a key role in inflammatory diseases. J Clin Invest 107: 7-11
39. Tiganis T, Kemp BE, Tongs NK (1999) The protein-tyrosine phosphatase TCPTP regulates epidermal growth factor receptor-mediated and phosphatidylinositol 3-kinase-dependent signaling. J Biol Chem 274: 27768-27775
40. Tummala PE, Chen XL, Sundell CL, Laursen JB, Hammes CP, Alexander RW, Harrison DG, Medford RM (1999) Angiotensin II induces vascular cell adhesion molecule-1 expression in rat vasculature: a potential link between the renin-angiotensin system and atherosclerosis. Circulation 100: 1223-1229
41. Wang C-Y, Mayo MW, Baldwin AS Jr (1996) TNF- and cancer therapy-induced apoptosis: potentiation by inhibition of NF-κB. Science 274: 784-789
42. _ Cusack JS Jr, Liu R, Baldwin AS Jr (1999) Control of inducible chemoresistance: enhanced anti-tumor therapy through increased apoptosis by inhibition of NF-κB. Nat Med 5: 412-417
43. Wang W, Abbruzzese JL, Evans DB, Larry L, Cleary KR, Chiao PJ (1999) The nuclear factor-κB RelA transcription factor is constitutively activated in human pancreatic adenocarcinoma cells. Clin Cancer Res 5: 110-127